Zobrazeno 1 - 10
of 2 973
pro vyhledávání: '"Bo, H"'
Autor:
Eric V. Mastrolonardo, Derek S. Mann, Harleen K. Sethi, Bo H. Yun, Elliott M. Sina, Maria Armache, Brooke Worster, Christopher E. Fundakowski, Leila J. Mady
Publikováno v:
Cancer Medicine, Vol 12, Iss 18, Pp 18882-18888 (2023)
Abstract Background Opioids are a mainstay in pain control for oncologic surgery. The objective of this systematic review is to evaluate the associations of perioperative opioid use with overall survival (OS) and disease‐free survival (DFS) in pati
Externí odkaz:
https://doaj.org/article/498c31d9aca946389406163da802e4e4
Publikováno v:
In Materials Characterization March 2024 209
Autor:
Taraldsen, Gunnar, Lindqvist, Bo H.
Publikováno v:
Communications in Statistics - Theory and Methods, 44: 3754-3767, 2015
The fiducial coincides with the posterior in a group model equipped with the right Haar prior. This result is here generalized. For this the underlying probability space of Kolmogorov is replaced by a $\sigma$-finite measure space and fiducial theory
Externí odkaz:
http://arxiv.org/abs/2006.09975
Autor:
Taraldsen, Gunnar, Lindqvist, Bo H.
Publikováno v:
Communications in Statistics - Theory and Methods, 45:17, 5007-5016
The purpose of this paper is to present a mathematical theory that can be used as a foundation for statistics that include improper priors. This theory includes improper laws in the initial axioms and has in particular Bayes theorem as a consequence.
Externí odkaz:
http://arxiv.org/abs/2006.04797
Publikováno v:
In Biotechnology Advances December 2023 69
In 1933 Kolmogorov constructed a general theory that defines the modern concept of conditional probability. In 1955 Renyi fomulated a new axiomatic theory for probability motivated by the need to include unbounded measures. We introduce a general con
Externí odkaz:
http://arxiv.org/abs/1812.01314
Publikováno v:
International Journal of Contemporary Hospitality Management, 2022, Vol. 34, Issue 8, pp. 2989-3007.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/IJCHM-09-2021-1182
Autor:
Jonathan W. Goldman, Lynette M. Sholl, Sanja Dacic, Michael C. Fishbein, Yonina R. Murciano-Goroff, Ravi Rajaram, Sylwia Szymczak, Anna M. Szpurka, Bo H. Chao, Alexander Drilon
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
The LIBRETTO-001 trial demonstrated the activity of the selective rearrangement during transfection (RET) inhibitor selpercatinib in advanced RET fusion-positive non-small cell lung cancer (NSCLC) and resulted in the drug’s approval for this indica
Externí odkaz:
https://doaj.org/article/ff2adc6f3eaf4f15b17c63e038b1aa62